This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Early Bird pricing expires in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
3 days in-person. 3 days virtually.
March 20–22, 2023 | Basel, SwitzerlandMarch 28–30, 2023 | Digital

AltrixBio Inc.

Profile

AltrixBio has developed LuCI™, a novel substance that transiently coats the GI mucosa to block nutrient absorption, independent of the pH environment, temporarily mimicking the effects of Gastric Bypass (RYGB). LuCI is comprised of a sucrose octasulfate aluminum complex engineered into a complex coacervate formulation linked via pH-independent electrostatic interactions. LuCI™ AJN 003 a reformulated drug with a 30-year safety profile in peptic ulcers which we have modified for T2D.